Intersect ENT, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
Intersect ENT, Inc. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of $40.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2021-03-09
- Intersect ENT, Inc. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2020 was $40.00K, a 6.98% decline from fiscal 2019.
- Intersect ENT, Inc. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2019 was $43.00K, a 65.32% decline from fiscal 2018.
- Intersect ENT, Inc. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2018 was $124.00K, a 67.57% increase from fiscal 2017.
- Intersect ENT, Inc. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2017 was $74.00K, a 6.33% decline from fiscal 2016.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|
| 2020-12-31 | $40.00K 10-K · filed 2021-03-09 |
| 2019-12-31 | $43.00K 10-K · filed 2021-03-09 |
| 2018-12-31 | $124.00K 10-K · filed 2021-03-09 |
| 2017-12-31 | $74.00K 10-K · filed 2020-02-27 |
| 2016-12-31 | $79.00K 10-K · filed 2019-02-28 |
| 2015-12-31 | $6.00K 10-K · filed 2018-02-28 |